APP and Alzheimer disease: A few clinical studies have revealed that some apolipoproteins are deregulated in AD patients [20], [54], and work on transgenic animal models suggests that some apolipoproteins have a role in processing of amyloid precursor protein (APP), Aβ metabolism and neurodegenerative processes [18], [22], [41] (figure 1).